Altogether, these findings motivate the investigation of the therapeutic efficacy of Smurf2 knockdown in treating CNKSR2-addicted cancers more effectively either as an individual therapy or in combination with already existing chemotherapy and/or radiotherapy. The gene discussed is SMURF2; the disease is cancer.